Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × durvalumab × Thoracic × Clear all

Phase

Status

Sponsor Class

OTHER 127 INDUSTRY 79 NIH 9 NETWORK 7 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Lymphoid 1 Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 12 Carboplatin 11 Pemetrexed 10 Drug Therapy 9 Gemcitabine 7 Docetaxel 7 Gefitinib 6 camrelizumab 5 Radiotherapy 5 Paclitaxel 5 Irinotecan 5 Erlotinib Hydrochloride 5 tislelizumab 4 apatinib 4 Nivolumab 4 Bevacizumab 4 Simvastatin 3 Platinum Compounds 3 Etoposide 3 Endostatins 3 toripalimab 2 surufatinib 2 pembrolizumab 2 olaparib 2 endostar protein 2 anlotinib 2 Topotecan 2 Thalidomide 2 Surgical Procedures, Operative 2 S 1 (combination) 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03446547 2023-11-14

ASTEROID

Vastra Gotaland Region

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡